MedPath

External therapy for Internal hemorrhoids in Siddha system of medicine

Phase 2
Conditions
Health Condition 1: K641- Second degree hemorrhoids
Registration Number
CTRI/2019/12/022465
Lead Sponsor
AyothidossPandithar Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Grade I - III hemorrhoids with complaints / History of bleeding per rectum episodes intermittently.

Patients signing the Informed consent form

Exclusion Criteria

Patients with History of Periproctitis or Hemorrhagic diathesis.

Patients with features of Severe Hepatic or cardiovascular disorders.

Patient with any type of Severe Infectious Disease.

Patients who have been involved with another experimental drug trial within past 30 days.

Patient presently diagnosed with Cancer.

Patients who have known alcohol and drug abuse.

Patients with abnormal values in blood and urine tests will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients with self reported assessment stating cured or improved compared with before treatment status and the objective assessment by investigator finding complete shrinking of pile mass and clearence of associated symptoms at the completion of treatment and 6 month post treatment.Modrate outcome: Partial reduction of pile mass and partiol relif of symptoms and/or reccurence within 6 months after cessation of treatment.Poor/Nil: No clearence of pile mass or no reduction of associated symptoms.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
Patients with self reported assessment stating cured or improved compared with before treatment status and the objective assessment by investigator finding complete shrinking of pile mass and clearence of associated symptoms at the completion of treatment and 6 month post treatment.Modrate outcome: Partial reduction of pile mass and partiol relif of symptoms and/or reccurence within 6 months after cessation of treatment.Poor/Nil: No clearence of pile mass or no reduction of associated symptoms.Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath